Mental and Substance Use
Disorders Prevalence Study (MDPS)
Existing collection in use without an OMB Control Number
No
Regular
03/29/2022
Requested
Previously Approved
36 Months From Approved
195,246
0
45,495
0
0
0
The study is a pilot program to
determine best methods for estimating the number of individuals
living with mental and substance use disorders, especially those of
the greatest severity. The primary goal of the MDPS is to examine
methods to provide unbiased and precise national prevalence
estimates of schizophrenia/schizoaffective disorder, bipolar
disorder, major depression, posttraumatic stress disorder (PTSD),
obsessive-compulsive disorder, generalized anxiety disorder, and
alcohol, benzodiazepine, opioid, stimulant, and cannabis use
disorders among U.S. adults ages 18 to 65.
Carlos Graham 204 276-0361
carlos.graham@samhsa.hhs.gov
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.